| | HEALTH ASPECTS OF BIOLOGICAL AND CHEMICAL WEAPONS |
| | 0,88 | | MB |
| | 179 | | stron |
| | 1017 | | ID | World Health Organization |
| | 2001 | | rok |
| | CONTENTS |
| | EXECUTIVE SUMMARY [pp ii-iii] |
| | LIST OF CONTRIBUTORS [to be prepared] [pp vi-vii] |
| | CHAPTER 1: INTRODUCTION [pp 1-5] |
| | 1.1 DEVELOPMENTS SINCE THE FIRST EDITION |
| | 1.2 ORIGIN AND PURPOSE OF THE PRESENT REPORT |
| | 1.3 SOME WORKING DEFINITIONS |
| | 1.4 STRUCTURE |
| | CHAPTER 2: ASSESSING THE THREAT TO PUBLIC HEALTH [pp 6-14] |
| | 2.1 CONTEXT |
| | 2.2 CHANGING TECHNOLOGY |
| | 2.3 NEW SCIENCE |
| | 2.4 A PRELIMINARY THREAT ASSESSMENT |
| | CHAPTER 3: BIOLOGICAL AND CHEMICAL AGENTS [pp 15-37] |
| | 3.1 SELECTION PRINCIPLES |
| | 3.1.1 Guidance from the international treaties |
| | …Box: How biological and chemical weapons are defined in the BWC and CWC |
| | Table 3.1: Biological agents variously cited as possible weapons |
| | 3.1.2 Guidance from the historical record |
| | Table 3.2: Toxic and infective agents weaponized since 1946 |
| | Table 3.3: Quantities of chemical agents declared to the OPCW |
| | Table 3.4: Instances of use of antipersonnel agents since 1919 |
| | 3.2 DISSEMINATION OF BIOLOGICAL AND CHEMICAL AGENTS |
| | 3.3 ROUTES OF EXPOSURE |
| | 3.3.1 Respiratory system |
| | 3.3.2 Skin and mucous membranes |
| | 3.3.3 Digestive system |
| | 3.4 CHARACTERISTICS OF BIOLOGICAL AGENTS |
| | 3.5 CHARACTERISTICS OF CHEMICAL AGENTS |
| | 3.6 CONSEQUENCES OF EMPLOYING BIOLOGICAL OR CHEMICAL WEAPONS |
| | 3.6.1 Short-term consequences |
| | 3.6.2 Long-term consequences |
| | 3.6.3 Psychological warfare aspects |
| | 3.7 ASSESSMENT AND CONCLUSIONS |
| | CHAPTER 4: PUBLIC HEALTH READINESS FOR BIOLOGICAL OR CHEMICAL INCIDENTS [pp |
| | 37-69] |
| | 4.1 PLANNING PRINCIPLES |
| | 4.2 PREPAREDNESS |
| | 4.2.1 Identify the hazards |
| | 4.2.2 Evaluate the hazards |
| | 4.2.3 Introduce risk reduction strategies |
| | Box: A six-step process for communicating with the public |
| | 4.2.4 Quantify the residual risk |
| | 4.2.5 Monitor the risk management programme |
| | 4.3 RESPONSE |
| | 4.3.1 Response before any overt release |
| | 4.3.2 Distinguishing features of biological and chemical incidents |
| | Table 4.1: Differentiation of biological and chemical attack |
| | 4.3.3 Response to biological incidents |
| | 4.3.4 Response to chemical incidents |
| | APPENDIX 4.1 THE SARIN INCIDENTS IN JAPAN |
| | APPENDIX 4.2 PROBLEMS RELATED TO PROTECTION |
| | CHAPTER 5: LEGAL CONTEXT [pp 70-80] |
| | 5.1 THE 1925 GENEVA PROTOCOL |
| | 5.2 THE 1972 BIOLOGICAL WEAPONS CONVENTION |
| | 5.2.1 International obligations |
| | 5.2.2 National implementation |
| | 5.3 THE 1993 CHEMICAL WEAPONS CONVENTION |
| | 5.3.1 International obligations |
| | 5.3.2 National implementation |
| | 5.4 CONCLUSION |
| | APPENDIX 5.1 BWC IMPLEMENTING LEGISLATION |
| | APPENDIX 5.2 CWC IMPLEMENTING LEGISLATION |
| | CHAPTER 6: INTERNATIONAL SOURCES OF ASSISTANCE [pp 81-90] |
| | 6.1 UNITED NATIONS |
| | 6.1.1 INVESTIGATION OF ALLEGED USE |
| | 6.1.2 HUMANITARIAN ASSISTANCE |
| | 6.2 ORGANISATION FOR THE PROHIBITION OF CHEMICAL WEAPONS |
| | 6.3 BIOLOGICAL WEAPONS CONVENTION |
| | 6.4 WORLD HEALTH ORGANIZATION |
| | 6.5 FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS |
| | 6.6 OFFICE INTERNATIONAL DES EPIZOOTIES |
| | 6.7 NON-GOVERNMENTAL ORGANISATIONS |
| | 6.9 CONTACT INFORMATION |
| | LITERATURE CITATIONS [pp 91-96] |